Altre lingue Amplia Therapeutics Limited

Azioni

ATX

AU0000023822

Mercato chiuso - Australian S.E. Altri mercati azionari 08:10:52 24/04/2024			Variaz. 5gg	Var. 1 gen.
0,064 ^AUD	+6,67%		-8,57%	-20,00%

27/03	Amplia conclude gli studi di Fase I del farmaco antitumorale; si prepara per la Fase II	MT
27/03	Amplia Therapeutics aggiorna sulla sperimentazione del cancro al pancreas; il reclutamento per la fase due è in corso; le azioni salgono del 3%.	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Amplia Therapeutics to Raise AU$4.3 Million for Cancer Trials, Drug Capsule Manufacturing	16/04
Amplia Concludes Phase I Trials of Anti-Cancer Drug; Prepares for Phase II	27/03
Amplia Therapeutics Updates on Pancreatic Cancer Trial; Phase-Two Recruitment Ongoing; Shares Up 3%	27/03
Amplia Therapeutics moves to next phase of pancreatic cancer treatment trial	14/02
Amplia Therapeutics Secures US FDA Clearance for Proposed Pancreatic Cancer Trial	18/01
Amplia Therapeutics Limited Announces FDA Clearance of it's IND for Pancreatic Cancer Trial in US	18/01
Amplia Therapeutics Doses First Patient in Phase 2A Pancreatic Cancer Trial	17/01
Amplia Therapeutics Secures South Korean Regulatory Approval for Pancreatic Cancer Trial; Shares Up 3%	04/12
Amplia Therapeutics Limited Reports Earnings Results for the Half Year Ended September 30, 2023	20/11
Amplia Therapeutics Receives AU$2.4 Million R&D Tax Rebate	19/10/23
Amplia Therapeutics Appoints CFO	25/09/23
Amplia Therapeutics Limited Announces Chief Financial Officer Changes	25/09/23
Amplia Therapeutics Gets Nod to Name Drug AMP945 Narmafotinib	23/06/23
Amplia Therapeutics Limited Reports Earnings Results for the Full Year Ended March 31, 2023	30/05/23
Amplia Therapeutics Limited Auditor Raises 'Going Concern' Doubt	30/05/23
Amplia secures funding to assess AMP945 topical applications	22/05/23
Amplia Therapeutics to Enter Research Collaboration with CSIRO; Shares Rise 7%	22/05/23
Amplia Receives Grant to Collaborate with CSIRO	22/05/23
Amplia Therapeutics Advances Clinical Trial for Pancreatic Cancer Inhibitor Drug	09/05/23
Amplia Therapeutics Doses First Patient for Third Cohort of Pancreatic Cancer Trial; Shares Rise 6%	19/04/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Amplia Therapeutics Limited

Azioni

ATX

AU0000023822

Altre lingue

Filtri